Ratings Dexterra Group Inc.

Equities

DXT

CA2523711091

Market Closed - Toronto S.E. 20:55:54 01/05/2024 BST 5-day change 1st Jan Change
5.87 CAD -0.34% Intraday chart for Dexterra Group Inc. +0.69% +1.91%

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • With a P/E ratio at 11.18 for the current year and 9.42 for next year, earnings multiples are highly attractive compared with competitors.
  • The company shows low valuation levels, with an enterprise value at 0.4 times its sales.
  • The company has a low valuation given the cash flows generated by its activity.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company sustains low margins.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Hotels, Motels & Cruise Lines

1st Jan change Capi. Investor Rating ESG Refinitiv
+1.91% 274M
B-
+8.59% 49.44B
B
+10.49% 15.96B
A-
+14.26% 15.07B
C+
+18.01% 10.92B
A-
+31.85% 9.84B
A-
+11.86% 5.05B
A
+3.83% 4.37B
C-
+23.60% 3.8B
B+
+88.02% 3.58B
C-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
-
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. DXT Stock
  4. Ratings Dexterra Group Inc.